MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Environmental risk factors and demographic of patients with Progressive Supranuclear Palsy from Argentina

    F. Rellan, B. Couto, F. Gonzalez Del-Boca, M. Paez Magio, C. Villa, E. Franchello, G. Alvarado, G. Mizraji, D. Nadile, C. Tanner, O. Gershanik, C. Marras (Buenos Aires, Argentina)

    Objective: To describe the environmental risk factors and family history in Argentinian patients with diagnosis of progressive supranuclear palsy (PSP). Background: Background: The current epidemiology…
  • 2024 International Congress

    Rapid Cognitive Deterioration and Related Factors in Progressive Supranuclear Palsy: a One-Year Follow-up Study

    XY. Li, G. Tang, FT. Liu, J. Wang (Shanghai, China)

    Objective: Based on a relatively large cohort, we aimed to show the switch of cognitive status in patients with progressive supranuclear palsy (PSP) after one-year follow-up…
  • 2024 International Congress

    Decoding non-IPD Parkinsonism – A Comparative Analysis of Atypical and Secondary Parkinsonism

    M. Acharya (Kharagpur, India)

    Objective: Using precise diagnostic criteria, the single-center observational study aims to evaluate the clinical profiles of non-IPD parkinsonism, specifically identifying crucial clinical clues for discriminating…
  • 2024 International Congress

    Frequency of Falls as a Presenti̇ng Symptom and Its Effect i̇n Prognosi̇s i̇n Progressi̇ve Supranuclear Palsy

    I. Kamacı, B. Marangozoglu Samanci, B. Zorlu Ucuncuoglu, E. Sahin, B. Bilgin, H. Hanağası (Istanbul, Turkey)

    Objective: We aimed to evaluate frequency of falls as a presenting symptom and its effect on prognosis in PSP patients. Background: Progressive supranuclear palsy is…
  • 2024 International Congress

    The Landscape of Interdisciplinary Care for Atypical Parkinsonism: A Qualitative Study from the CurePSP Centers of Care

    D. Shpiner, J. Shurer, F. Ali, M. Barrett, A. Brown, A. Duquette, J. Fleisher, G. Lamotte, A. Pantelyat, S. Reichwein, F. Rodriguez-Porcel, J. Siddiqui, M. Sklerov, C. Spears, T. Virmani, R. Akhtar (Miami, USA)

    Objective: To define interdisciplinary care practices for progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA). Background: PSP, CBS, and MSA are…
  • 2024 International Congress

    Longitudinal progress and clinical relevance of 18F-Florzolutau PET in patients with PSP: a one-year follow-up study

    J. Wang, F. Liu, C. Zuo (Shanghai, China)

    Objective: Here we aimed to explore the progress of 18F-Florzolotau PET and its clinical relevance in patients with PSP during one-year follow-up. Background: The 18F-Florzolotau…
  • 2024 International Congress

    Paraneoplastic neurological syndrome mimicking a progressive supranuclear palsy: a case series

    R. Zouari, F. Nabli, A. Rachdi, D. Ben Mohamed, MZ. Saeid, S. Ben Sassi (Tunis, Tunisia)

    Objective: we describe 2 patients with paraneoplastic parkinsonism mimicking a PSP. Background: Paraneoplastic neurological syndromes (PNS) are broad-spectrum disorders that can affect any part of…
  • 2024 International Congress

    Multiple System Atrophy in a Patient with Normal Pressure Hydrocephalus

    E. Hayden, M. Elkasaby, B. Appleby (Cleveland, USA)

    Objective: To review a case of a patient diagnosed with both NPH and MSA. Background: Multiple system atrophy (MSA) is a progressive neurodegenerative disease that…
  • 2024 International Congress

    Pain types in multiple system atrophy: results from a community-based survey

    N. Campese, G. Göbel, L. Kaltenbach, J. Wanschitz, A. Schlager, B. Caliò, F. Leys, P. Bower, L. Kellermann, L. Zamarian, K. Bannister, R. Chauhuri, A. Schrag, R. Freeman, H. Kaufmann, R. Granata, S. Kiechl, W. Poewe, K. Seppi, G. Wenning, A. Fanciulli (Innsbruck, Austria)

    Objective: To assess the frequency of different pain types in multiple system atrophy (MSA). Background: According to a recent meta-analysis, up to 60% of individuals…
  • 2024 International Congress

    Prospective Study of Gait and Multimodal MRI Biomarkers for Multiple System Atrophy

    F. Marchand, R. Viard, D. Devos, L. Defebvre, T. Ollivier, D. Guehl, G. Kuchcinski, C. Moreau (LILLE, France)

    Objective: We aimed to develop new multimodal biomarkers allowing objective monitoring of early MSA progression to improve outcome definition for future neuroprotective trials. Background: MSA…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley